What has been the main impact of MFN?

It is not bringing down US prices, but delaying launches in Europe. Reuters reports: Drug launches in EU markets fell by some 35% in the 10 months since Trump’s executive order, compared with the previous ​10 months…Delaying launches at lower EU prices could help secure higher U.S. prices for longer. You can read the full…

How did China become a global leader in life sciences?

An NBER working paper by Barwick, Xia and Xia (2026) provides the answer: In 2010, China accounted for less than 8% of global clinical trials; by 2020, it had surpassed the US in annual registered clinical trial volume…We provide strong evidence that China’s rise was primarily driven by the National Reimbursement Drug List (NRDL) reform,…

Why do U.S. physicians make so much money?

Let’s look at some data on mean annual physician income in the U.S. compared to other countries: U.S.: $458,100 Canada: $194,700 Netherlands: $185,700 Sweden: $115,200 Why are U.S. physician incomes so much higher than other developed countries? Is it a good idea to try to drive down physician incomes? An NBER working paper by Buehler…

High deductible health plans: Lessons from Singapore

Republicans are pushing for increased use of high deductible health plans (HDHP). HDHPs have increased over time, from 29% of all employer health plans in 2021 to 33% of all employer health plans in 2025. One country that has successfully used HDHP is Singapore. A 2020 Commonweath Fund Report summarizes 3 components of the Singapore’s…

Is Caring Productive?

That is the title of a paper by Longo et al. (2025). The authors use dynamic panel data on Adult Social Care (ASC) in the UK. What is ASC include: A quick explainer about ASC in the UK: In England, there are 152 upper-tier local authorities (LAs) who are responsible for publicly-funded ASC services. Access…

Will the UK (finally) increase drug prices?

President Trump’s May 12 Executive Order around Most-Favored-Nation drug pricing argues that countries outside the US need to raise their prices on pharmaceuticals saying that many other countries are “freeloading” and paying less than their share for pharmaceuticals. In response, pharmaceutical companies have increased prices in the UK and even threatened to “walk away” from…

What’s in the UK’s Life Sciences Sector Plan?

Yesterday, the UK government released it’s Life Sciences Sector Plan (LSSP). The British government summarized the provisions as follows: 1. Unlocking NHS data to find new cures. Up to £600 million investment to build the world’s most advanced health data system – helping scientists develop better treatments faster. 2. Speeding up clinical trials. Cutting red…